The arrival of the drug in Oz is generating significant excitement within the healthcare community. This novel dual medication – acting on both GLP-1 and GIP targets – shows a remarkably powerful option for https://bpc-157-australia994844.wikihearsay.com/4626702/australia_s_retatrutide_australia_a_fresh_approach_for_weight_management